Back to HomeBeta

ICD-10 Coding for Prostate-Derived Factor(C61.9, R97.21)

Complete ICD-10-CM coding and documentation guide for Prostate-Derived Factor. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

PDEFSPDEF

Related ICD-10 Code Ranges

Complete code families applicable to Prostate-Derived Factor

C61-C63Primary Range

Malignant neoplasms of male genital organs

This range includes prostate cancer, which is associated with prostate-derived factor involvement.

Abnormal findings on examination of blood, without diagnosis

This range includes codes for elevated tumor markers such as PSA, which may be influenced by prostate-derived factor.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C61.9Malignant neoplasm of prostate, unspecifiedUse when prostate cancer is confirmed and PDF is involved.
  • Histopathological confirmation of prostate cancer
  • Elevated PDF levels correlating with aggressive phenotype
R97.21Elevated prostate-specific antigen [PSA]Use when elevated PSA is documented alongside PDF involvement.
  • PSA > 20 ng/mL with PDF overexpression

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for prostate-derived factor

Essential facts and insights about Prostate-Derived Factor

Prostate-derived factor is linked to prostate cancer, coded as C61.9, with additional codes for biomarker involvement.

Primary ICD-10-CM Codes for prostate derived factor

Malignant neoplasm of prostate, unspecified
Non-billable Code

Decision Criteria

clinical Criteria

  • Confirmed prostate cancer with PDF involvement

Applicable To

  • Prostate cancer

Excludes

  • Benign prostatic hyperplasia

Clinical Validation Requirements

  • Histopathological confirmation of prostate cancer
  • Elevated PDF levels correlating with aggressive phenotype

Code-Specific Risks

  • Omitting PDF's role in documentation

Coding Notes

  • Ensure PDF's role in cancer progression is documented.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Other estrogen receptor status

Z17.8
Use if PDF expression correlates with androgen receptor positivity.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Secondary malignant neoplasm of genital organs

C79.82
Use if PDF overexpression is linked to metastatic spread.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Prostate-Derived Factor to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C61.9.

Impact

Clinical: Inaccurate assessment of cancer aggressiveness., Regulatory: Non-compliance with documentation standards., Financial: Potential loss of reimbursement.

Mitigation Strategy

Always document PDF levels and role, Use templates for consistency

Impact

Reimbursement: Incomplete coding may lead to reduced reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate data on tumor marker involvement.

Mitigation Strategy

Add Z17.8 and 0047U for comprehensive coding.

Impact

Lack of quantitative PDF data in records.

Mitigation Strategy

Ensure all PDF levels and methods are documented.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Prostate-Derived Factor, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Prostate-Derived Factor

Use these documentation templates to ensure complete and accurate documentation for Prostate-Derived Factor. These templates include all required elements for proper coding and billing.

Prostate cancer with PDF involvement

Specialty: Oncology

Required Elements

  • PDF serum level
  • Testing method
  • Clinical correlation

Examples: Poor vs. Good Documentation

Poor Documentation Example
Elevated tumor markers
Good Documentation Example
PDF level 52 ng/mL (ref: <15) via LSBio ELISA kit #LS-F1234, confirming active PDEF/SPDEF pathway involvement.
Explanation
The good example provides specific levels, methodology, and clinical correlation.

Need help with ICD-10 coding for Prostate-Derived Factor? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more